Press release content from Business Wire. The AP news staff was not involved in its creation.
AlloVir Announces Data Presentations at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience
January 11, 2021 GMT
CAMBRIDGE, Mass. (BUSINESS WIRE) Jan 11, 2021
AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, announced that it will present three oral presentations and one poster presentation during the Transplantation & Cellular Therapy Meeting of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) taking place virtually February 8 – 12, 2021.
Details of the oral presentations are as follows:
Assigned session: Oral Abstract - Session C - Health Services